Seven Fleet Capital Management LP Acquires New Stake in Adlai Nortye Ltd. Sponsored ADR $ANL

Seven Fleet Capital Management LP acquired a new stake in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 113,207 shares of the company’s stock, valued at approximately $1,302,000. Seven Fleet Capital Management LP owned about 0.28% of Adlai Nortye as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in ANL. Braidwell LP purchased a new stake in shares of Adlai Nortye during the second quarter valued at $9,145,000. Boone Capital Management LLC purchased a new position in Adlai Nortye in the 2nd quarter worth about $2,971,000. Affinity Asset Advisors LLC bought a new stake in Adlai Nortye during the 1st quarter valued at about $1,140,000. ADAR1 Capital Management LLC purchased a new stake in Adlai Nortye in the 1st quarter valued at about $816,000. Finally, Renaissance Technologies LLC bought a new position in Adlai Nortye in the 1st quarter worth about $457,000. 35.21% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Adlai Nortye news, CFO Xiaofeng Ye sold 5,667 shares of Adlai Nortye stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $14.25, for a total value of $80,754.75. Following the transaction, the chief financial officer directly owned 147,757 shares of the company’s stock, valued at approximately $2,105,537.25. The trade was a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Adlai Nortye Stock Up 9.6%

ANL stock opened at $15.06 on Thursday. Adlai Nortye Ltd. Sponsored ADR has a one year low of $0.88 and a one year high of $17.25. The company has a debt-to-equity ratio of 0.04, a current ratio of 9.55 and a quick ratio of 0.65. The firm has a 50-day simple moving average of $12.00 and a two-hundred day simple moving average of $11.16.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ANL. Oppenheimer started coverage on Adlai Nortye in a report on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price target for the company. Wall Street Zen upgraded Adlai Nortye from a “hold” rating to a “buy” rating in a research note on Saturday, August 22nd. JonesTrading started coverage on Adlai Nortye in a report on Thursday, May 14th. They issued a “buy” rating and a $22.00 price objective for the company. Cantor Fitzgerald started coverage on shares of Adlai Nortye in a research note on Monday, June 22nd. They set an “overweight” rating on the stock. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $24.25.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.